| Surgery Partners, Inc. (SGRY) Q1 2025 Earnings Call Transcript |
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Eric Evans - Chief Executive Officer David Doherty - Executive Vice President and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Benjamin Rossi - JPMorgan Chase Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Albert Rice - UBS William Spivack - TD Cowen Matthew Gillmor - KeyBanc Capital Markets Whit Mayo - Leerink Partners Benjamin Hendrix - RBC Operator Greetings, and welcome to Surgery Partners' First Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. |
seekingalpha.com |
2025-05-12 19:23:33 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates |
Surgery Partners (SGRY) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.10 per share a year ago. |
zacks.com |
2025-05-12 13:46:03 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance |
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. |
globenewswire.com |
2025-05-12 11:30:00 |
Czytaj oryginał (ang.) |
| Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care |
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence, and continuous learning. With the addition of Dr. Joseph Raniere, Jr., Dr. Edward S. Gronka, and Dr. Takintope Akinbiyi as Partner Physicians, as well as Amanda Fowler, PA-C, Ascend now includes 24 physicians across six states—and a growing community—working together to advance the field of aesthetic medicine. |
globenewswire.com |
2025-05-06 11:00:00 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details |
BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). |
globenewswire.com |
2025-04-18 18:09:00 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. (SGRY) Q4 2024 Earnings Call Transcript |
Surgery Partners, Inc. (NASDAQ:SGRY ) Q4 2024 Earnings Conference Call March 3, 2025 8:30 AM ET Company Participants Eric Evans - Chief Executive Officer Dave Doherty - Executive Vice President and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J. Rice - Credit Suisse Tao Qiu - Macquarie Research Andrew Mok - Barclays Matthew Gillmor - KeyBanc Capital Markets Whit Mayo - SVB Leerink Sarah James - Cantor Fitzgerald Operator Greetings. |
seekingalpha.com |
2025-03-03 15:34:02 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates |
Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.44 per share a year ago. |
zacks.com |
2025-03-03 11:40:23 |
Czytaj oryginał (ang.) |
| These 2 REITs Make Great Buys For Income Investors |
REITs have surged in value. But opportunities still remain for income-oriented investors. I present two REITs to buy today. |
seekingalpha.com |
2025-02-27 10:25:00 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details |
BRENTWOOD, Tenn., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2024 results before the market opens on Monday, March 3, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). |
globenewswire.com |
2025-02-18 09:30:00 |
Czytaj oryginał (ang.) |
| Japan In The Spotlight; Blockchain In AI's Shadow |
As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. The value of private equity investment in Japan jumped nearly 41% over the prior-year total in 2024, far outpacing the 25% year-over-year gain in global private equity deal value, according to S&P Global Market Intelligence data. |
seekingalpha.com |
2025-02-01 00:30:00 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Surges 21.2%: Is This an Indication of Further Gains? |
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
zacks.com |
2025-01-29 07:30:53 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital |
BRENTWOOD, Tenn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced that its Board of Directors (the “Board”) received a non-binding proposal, dated January 27, 2025, from Bain Capital Private Equity, LP (“Bain Capital”) to acquire all of the outstanding shares of Surgery Partners not already owned by Bain Capital for a cash consideration of $25.75 per share (the “Bain Capital Proposal”). Bain Capital and its affiliates own approximately 39% of the Company's outstanding common stock, based on the Schedule 13D/A filing dated January 28, 2025. |
globenewswire.com |
2025-01-28 15:03:00 |
Czytaj oryginał (ang.) |
| Bain Capital proposes to acquire remaining shares of Surgery Partners |
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on Tuesday. |
reuters.com |
2025-01-28 11:34:05 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors |
BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. |
globenewswire.com |
2025-01-13 19:00:00 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript |
Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies Joanna Gajuk - Bank of America A.J. Rice - UBS Andrew Mok - Barclays Tao Qiu - Stifel Sarah James - Cantor Fitzgerald Bill Sutherland - The Benchmark Company Benjamin Rossi - JPMorgan Will Spivack - TD Cowen Operator Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call. |
seekingalpha.com |
2024-11-12 16:55:21 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Misses Q3 Earnings Estimates |
Surgery Partners (SGRY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.19 per share a year ago. |
zacks.com |
2024-11-12 11:56:11 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release |
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-11-05 13:05:28 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details |
BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2024 results before the market opens on Tuesday, November 12, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time). |
globenewswire.com |
2024-10-21 15:50:00 |
Czytaj oryginał (ang.) |
| Here's Why Surgery Partners Could Be the Next Hot Takeover |
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company. |
benzinga.com |
2024-09-27 17:47:00 |
Czytaj oryginał (ang.) |
| Here's Why Surgery Partners Could Be the Next Hot Takeover |
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company. |
marketbeat.com |
2024-09-25 12:30:06 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Meets Q2 Earnings Estimates |
Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago. |
zacks.com |
2024-08-06 13:40:20 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces Second Quarter 2024 Results Raises Full Year 2024 Guidance |
BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024. |
globenewswire.com |
2024-08-06 11:30:00 |
Czytaj oryginał (ang.) |
| SGRY or MEDP: Which Is the Better Value Stock Right Now? |
Investors looking for stocks in the Medical Services sector might want to consider either Surgery Partners (SGRY) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2024-08-01 16:41:32 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call Details |
BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2024 results before the market opens on Tuesday, August 6, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time) |
globenewswire.com |
2024-07-16 20:05:00 |
Czytaj oryginał (ang.) |
| SGRY vs. MEDP: Which Stock Is the Better Value Option? |
Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2024-07-16 16:45:49 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Think Surgery Partners (SGRY) Could Surge 57.53%: Read This Before Placing a Bet |
The mean of analysts' price targets for Surgery Partners (SGRY) points to a 57.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
zacks.com |
2024-07-12 14:56:10 |
Czytaj oryginał (ang.) |
| Sheridan Capital Partners-Backed Oral Surgery Partners Announces $75M Credit Expansion |
CHICAGO--(BUSINESS WIRE)--Oral Surgery Partners (“OSP”) announced today the closing of a $75 million credit expansion. The facility expansion was provided by the existing lending partners and will allow OSP to continue to grow through 2024 and beyond. “OSP's lenders continue to show strong support for the company due to its well-established track record and continued performance. We're excited to have like-minded lending partners who share the vision of providing excellent care in oral surgery. |
businesswire.com |
2024-06-20 11:00:00 |
Czytaj oryginał (ang.) |
| Natixis Advisors L.P. Has $375,000 Position in Surgery Partners, Inc. (NASDAQ:SGRY) |
Natixis Advisors L.P. raised its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 8.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,735 shares of the company’s stock after purchasing an additional 934 shares during the period. Natixis Advisors L.P.’s holdings in Surgery Partners were worth $375,000 as of its most recent SEC filing. A number of other institutional investors also recently modified their holdings of SGRY. Amalgamated Bank raised its holdings in Surgery Partners by 7.6% in the 3rd quarter. Amalgamated Bank now owns 9,948 shares of the company’s stock worth $291,000 after acquiring an additional 701 shares during the period. Raymond James & Associates lifted its position in shares of Surgery Partners by 1.2% during the 3rd quarter. Raymond James & Associates now owns 61,188 shares of the company’s stock worth $1,790,000 after purchasing an additional 736 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in Surgery Partners by 69.7% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company’s stock valued at $86,000 after purchasing an additional 1,210 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in Surgery Partners in the 3rd quarter valued at approximately $39,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in Surgery Partners by 15.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,506 shares of the company’s stock worth $307,000 after buying an additional 1,387 shares during the period. Insider Buying and Selling In other Surgery Partners news, CEO Jason Eric Evans sold 4,840 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total value of $143,796.40. Following the transaction, the chief executive officer now owns 459,670 shares of the company’s stock, valued at $13,656,795.70. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.60% of the stock is owned by corporate insiders. Surgery Partners Stock Performance Shares of NASDAQ:SGRY opened at $25.83 on Monday. The stock has a market capitalization of $3.28 billion, a price-to-earnings ratio of 30.76, a price-to-earnings-growth ratio of 2.04 and a beta of 2.75. The business’s fifty day moving average price is $26.82 and its two-hundred day moving average price is $30.01. Surgery Partners, Inc. has a fifty-two week low of $22.05 and a fifty-two week high of $45.79. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.71 and a quick ratio of 1.56. Surgery Partners (NASDAQ:SGRY – Get Free Report) last posted its earnings results on Monday, February 26th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. The business had revenue of $735.40 million for the quarter, compared to analyst estimates of $741.93 million. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.22 EPS. As a group, analysts predict that Surgery Partners, Inc. will post 0.84 EPS for the current fiscal year. Wall Street Analysts Forecast Growth Several equities research analysts have recently issued reports on SGRY shares. StockNews.com upgraded shares of Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, March 21st. Royal Bank of Canada reiterated an “outperform” rating and issued a $49.00 target price on shares of Surgery Partners in a research note on Thursday, February 29th. Barclays initiated coverage on Surgery Partners in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 price target for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a report on Wednesday, April 10th. Finally, Benchmark restated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Wednesday, May 1st. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $43.13. Read Our Latest Analysis on Surgery Partners Surgery Partners Profile (Free Report) Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. |
https://www.defenseworld.net |
2024-05-20 08:54:49 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. (SGRY) Q1 2024 Earnings Call Transcript |
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2024 Results Conference Call May 4, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies Whit Mayo - SVB Leerink Kevin Fischbeck - Bank of America Andrew Mok - Barclays Sarah James - Cantor Fitzgerald Gary Taylor - TD Cowen Bill Sutherland - The Benchmark Company Jason Cassorla - Citi Cal Sternick - JPMorgan Chase Ben Hendrix - RBC Capital Markets Operator Greetings. Welcome to Surgery Partners First Quarter 2024 Earnings Call. |
seekingalpha.com |
2024-05-08 02:55:24 |
Czytaj oryginał (ang.) |
| Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates |
Surgery Partners (SGRY) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.08 per share a year ago. |
zacks.com |
2024-05-07 13:41:12 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces First Quarter 2024 Results |
BRENTWOOD, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024. |
globenewswire.com |
2024-05-07 11:30:00 |
Czytaj oryginał (ang.) |
| Earnings Preview: Surgery Partners (SGRY) Q1 Earnings Expected to Decline |
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-04-30 15:05:57 |
Czytaj oryginał (ang.) |
| Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details |
BRENTWOOD, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time). |
globenewswire.com |
2024-04-18 05:06:00 |
Czytaj oryginał (ang.) |
| SGRY vs. DOCS: Which Stock Should Value Investors Buy Now? |
Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Doximity (DOCS). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2024-04-11 16:41:03 |
Czytaj oryginał (ang.) |